To whom XCLARIS is addressed
XCLARIS BRCA Panel is particularly indicated in:
- Familiarity for breast, ovarian, pancreatic or prostate cancer in three or more cases in the same family branch
- Patients with non-mucinous and non-borderline ovarian carcinoma, fallopian tube carcinoma or primary peritoneal carcinoma
- Woman with breast cancer before the age of 36
- Woman with breast cancer and ovarian cancer
- Woman with triple negative breast cancer under the age of 60
- Woman with bilateral breast cancer less than 50 years old
- Male breast cancer
- Patients with metastatic pancreatic cancer